Eye drops tested to help millions read without glasses

NCT ID NCT05728944

Summary

This Phase 3 study tested whether LNZ101 eye drops are safe and effective for improving near vision in people with presbyopia, the age-related blurriness that makes reading difficult. It involved 229 adults aged 45-75 who needed reading glasses. The main goal was to see if the drops could significantly improve close-up vision without harming distance vision.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EYE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site #203

    Newport Beach, California, 92663, United States

  • Site #204

    Danbury, Connecticut, 06810, United States

  • Site #205

    Crystal River, Florida, 34429, United States

  • Site #207

    Powell, Ohio, 43065, United States

  • Site #208

    St Louis, Missouri, 63128, United States

  • Site #209

    Dothan, Alabama, 36301, United States

  • Site #211

    Louisville, Kentucky, 40206, United States

  • Site #212

    West Fargo, North Dakota, 58078, United States

  • Site #213

    Eugene, Oregon, 97401, United States

  • Site #214

    La Jolla, California, 92037, United States

  • Site #215

    Bozeman, Montana, 59718, United States

  • Site #216

    Scottsdale, Arizona, 85260, United States

  • Site #217

    Warwick, Rhode Island, 02888, United States

  • Site #218

    Northbrook, Illinois, 60062, United States

  • Site #219

    Dover, New Jersey, 07801, United States

  • Site #220

    Glendale, California, 91204, United States

  • Site #221

    Rochester, New York, 14626, United States

Conditions

Explore the condition pages connected to this study.